American Vanguard Corporation (AVD) reported that director Scott Baskin was awarded 8,810 shares of common stock on 08/07/2025 as part of the company’s non-management director compensation program. The shares were granted at a price of $0, reflecting an award rather than an open-market purchase.
Following the grant, Mr. Baskin’s reported beneficial ownership increased to 41,997 shares. The filing identifies Mr. Baskin as a director and notes the award was connected to the 2025 annual stockholders' meeting. This is a routine equity award disclosed on Form 4 and does not include additional transactions or derivative positions.
Patrick E. Gottschalk, a director of American Vanguard Corporation (AVD), was awarded 17,621 deferred stock units (DSUs) on 08/07/2025 as part of the companys non-management director compensation program. Each DSU represents the right to receive one share of common stock upon settlement when the recipients service with the company ends; while outstanding the DSUs are nontransferable and carry neither voting nor dividend rights.
Following the award, Gottschalks reported beneficial ownership of AVD common stock is 79,424 shares (direct). The DSUs were granted at a reported price of $0 and are subject to the companys standard DSU agreement.
American Vanguard (AVD) Q2-25 10-Q highlights:
- Net sales grew 1% YoY to $129.3 m; U.S. crop +1%, U.S. non-crop +3%, International flat.
- Cost-of-sales fell 2%, lifting gross margin to 31% (29% LY). Gross profit +7% to $40.5 m.
- Operating expenses -23% to $36.2 m as transformation spending fell to $1.6 m (vs $7.3 m). Operating income swung to $4.4 m (-$9.2 m).
- After $4.5 m net interest and $0.8 m tax expense, quarterly net loss narrowed sharply to $0.8 m (-$11.7 m); EPS -$0.03.
- 1H-25: revenue -7% to $245.1 m; gross margin 29% (30% LY); operating break-even ($0.1 m); net loss $9.3 m vs -$10.2 m.
- Cash used in operations -$39.8 m (vs -$49.4 m LY) driven by $46.2 m drawdown of customer prepayments and $9.8 m inventory build.
- Debt climbed to $189.5 m (12/24: $147.3 m); average borrowing rate 8.4% Q2.
- May-25 Eleventh Amendment cut revolver to $245 m and suspended leverage & FCCR covenants through 2025, adding minimum liquidity & EBITDA tests. Company had $31.8 m available capacity at 6-30-25.
- No dividends permitted under amended facility.
- Material weaknesses in ICFR (Australia, close process, risk assessment) persist.
- Legal exposure: out-of-spec insecticide lots may create material claims; loss not yet estimable.
Management sees early ag-market recovery, expects lower transformation spend and continues talks to extend credit facility (matures Aug-26).